Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'small cell lung cancer' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1320 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Roberto Ravasio
      Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

      Farmeconomia e percorsi terapeutici
    2. Argiris, A; Murren, JR
      Staging and clinical prognostic factors for small-cell lung cancer

      CANCER JOURNAL
    3. Argiris, A; Murren, JR
      Advances in chemotherapy for small cell lung cancer: Single-agent activityof newer agents

      CANCER JOURNAL
    4. Psyrri, A; Murren, J
      Small cell lung cancer: Strategies to optimize chemotherapy response

      CANCER JOURNAL
    5. Sakamoto, J; Teramukai, T; Watanabe, Y; Hayata, Y; Okayasu, T; Nakazato, N; Ohashi, Y
      Mete-analysis of adjuvant immunochemotherapy using OK-432 in patients withresected non-small-cell lung cancer

      JOURNAL OF IMMUNOTHERAPY
    6. Dai, ZY; Lakshmanan, RR; Zhu, WG; Smiraglia, DJ; Rush, LJ; Fruhwald, MC; Brena, RM; Li, B; Wright, FA; Ross, P; Otterson, GA; Plass, C
      Global methylation profiling of lung cancer identifies novel methylated genes

      NEOPLASIA
    7. Pedersen, MWB; Holm, S; Lund, EL; Hojgaard, L; Kristjansen, PEG
      Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro

      NEOPLASIA
    8. Kallab, AM; Jillella, AP
      Tumor lysis syndrome in small cell lung cancer

      MEDICAL ONCOLOGY
    9. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Plosker, GL; Hurst, M
      Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer

      PHARMACOECONOMICS
    11. Cuomo, AM; Della Cuna, FSR; Baiardi, P; Torazzo, R; Preti, P; Della Cuna, GR
      Three conventional-drug combination (ifosfamide, carboplatin, etoposide-ICE regimen) in advanced non-small cell lung cancer (NSCLC)

      JOURNAL OF CHEMOTHERAPY
    12. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    13. Nanni, L; Palomba, G; Morelli, F; Piano, A; Simeone, A; D'Alessandro, V; Sirotova, Z; Capuano, G; Rinaldi, B; Lelli, G
      Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer: A phase I-II study

      JOURNAL OF CHEMOTHERAPY
    14. Han, H; Silverman, JF; Santucci, TS; Macherey, RS; dAmato, TA; Tung, MY; Weyant, RJ; Landreneau, RJ
      Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis

      ANNALS OF SURGICAL ONCOLOGY
    15. Brescia, FJ
      Lung cancer - a philosophical, ethical, and personal perspective

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    16. Choy, H
      Taxanes in combined modality therapy for solid tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    17. Grossi, F; Scolaro, T; Tixi, L; Loprevite, M; Ardizzoni, A
      The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    18. Saitoh, G; Sugio, K; Ishida, T; Sugimachi, K
      Prognostic significance of p21(waf1), cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

      ONCOLOGY REPORTS
    19. Higashiyama, M; Kodama, K; Yokouchi, H; Takami, K; Nakagawa, H; Imamura, F; Minamigawa, K; Kobayashi, H
      Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: Relation of the in vitro chemosensitive test to clinical response

      ONCOLOGY REPORTS
    20. Changlai, SP; Tsai, SC; Chou, MC; Ho, YJ; Kao, CH
      Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer

      ONCOLOGY REPORTS
    21. Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, A
      Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study

      ONCOLOGY REPORTS
    22. Pritchard, SC; Nicolson, MC; Lloret, C; McKay, JA; Ross, VG; Kerr, KM; Murray, GI; McLeod, HL
      Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy

      ONCOLOGY REPORTS
    23. Ubagai, T; Matsuura, S; Tauchi, H; Itou, K; Komatsu, K
      Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer

      ONCOLOGY REPORTS
    24. Lui, WO; Tanenbaum, DM; Larsson, C
      High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas

      INTERNATIONAL JOURNAL OF ONCOLOGY
    25. Kurakawa, E; Shimamoto, T; Utsumi, K; Hirano, T; Kato, H; Ohyashiki, K
      Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lungcancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    26. Nozaki, I; Tsuji, T; Iijima, O; Ohmura, Y; Andou, A; Miyazaki, M; Shimizu, N; Namba, M
      Reduced expression of REIC/Dkk3 gene in non-small cell lung cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    27. Naruke, M; Abe, Y; Hatanaka, H; Ohnishi, Y; Yamazaki, H; Kijima, H; Nakamura, M; Ueyama, Y; Kobayashi, K
      Interleukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts

      INTERNATIONAL JOURNAL OF ONCOLOGY
    28. Kara, M; Sak, SD; Orhan, D; Kavukcu, S
      Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    29. Mineo, TC; Ambrogi, V; Corsaro, V; Roselli, M
      Postoperative adjuvant therapy for stage IB non-small-cell lung cancer

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    30. Lewinski, T; Zulawski, M; Turski, C; Pietraszek, A
      Small cell lung cancer I-III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    31. Margaritora, S; Cesario, A; Galetta, D; D'Andrilli, A; Macis, G; Mantini, G; Trodella, L; Granone, P
      Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    32. Daniels, JMA; Rijna, H; Postmus, PE; van Mourik, JC
      Mediastinoscopy as a standardised procedure for mediastinal lymph node staging in non-small cell lung carcinoma

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    33. Szopinski, J; von Kleist, S; Rowinska-Zakrzewska, E; Panorska, A; Roginska, E; Rogala, E
      Interferon gamma and interleukin-2 secretion in whole blood cell cultures from small-cell lung cancer patients

      TUMOR BIOLOGY
    34. Kristiansen, G; Petersen, YYS; Kaufmann, O; Schluns, K; Dietel, M; Petersen, I
      Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    35. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    36. Laack, E; Mende, T; Benk, J; Chemaissani, A; Scholtze, J; Lorenz, C; Niestroy, A; Dalhoff, K; Muller, T; Walter, T; Durk, H; Edler, L; Hossfeld, DK
      Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

      EUROPEAN JOURNAL OF CANCER
    37. Coudert, B; Anthoney, A; Fiedler, W; Droz, JP; Dieras, V; Borner, M; Smyth, JF; Morant, R; de Vries, MJ; Roelvink, M; Fumoleau, P
      Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group Report

      EUROPEAN JOURNAL OF CANCER
    38. Supino, R; Perego, P; Gatti, L; Caserini, C; Leonetti, C; Colantuono, M; Zuco, V; Carenini, N; Zupi, G; Zunino, F
      A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line

      EUROPEAN JOURNAL OF CANCER
    39. Oka, M; Fukuda, M; Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Soda, H; Takatani, H; Narasaki, F; Nagashima, S; Nakamura, YI; Hayashi, N; Kohno, S
      Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    40. Baron, F; Cueva, J; Grana, B; Curiel, T; Leon, L; Vazquez, F; Candamio, S; Lopez, R
      Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    41. Bunn, PA
      State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer

      ANTI-CANCER DRUGS
    42. Crino, L; Cappuzzo, F
      Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials

      ANTI-CANCER DRUGS
    43. Van Zandwijk, N
      Non-small cell lung cancer neoadjuvant chemotherapy: the benefits of gemcitabine

      ANTI-CANCER DRUGS
    44. Le Chevalier, T
      Multi-targeted antifolate therapy for non-small cell lung cancer and mesothelioma

      ANTI-CANCER DRUGS
    45. Gandara, DR; Lara, PN; Goldberg, Z; Roberts, P; Lau, DHM
      Neoadjuvant therapy for non-small cell lung cancer

      ANTI-CANCER DRUGS
    46. Pavey, SJ; Hawson, GAT; Marsh, NA
      Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma

      BLOOD COAGULATION & FIBRINOLYSIS
    47. van der Linden, YM; van Kempen, ML; van der Tweel, I; Vanderschueren, RGJRA; Schlosser, JJ; Lammers, JWJ; Struikmans, H
      Prophylactic cranial irradiation in limited disease small-cell lung cancerin complete remission: a retrospective analysis

      RESPIRATORY MEDICINE
    48. Meuwissen, R; Linn, SC; van der Valk, M; Mooi, WJ; Berns, A
      Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

      ONCOGENE
    49. Dammann, R; Takahashi, T; Pfeifer, GP
      The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas

      ONCOGENE
    50. Kloke, O
      Chemotherapy of elderly patients with non-small-cell lung cancer

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    51. Ferrigno, D; Buccheri, G
      Anthropometric measurements in non-small-cell lung cancer

      SUPPORTIVE CARE IN CANCER
    52. Nomori, H; Horio, H; Suemasu, K
      Differentiating early malignant lung tumors from inflammatory nodules to minimize the use of video-assisted thoracoscopic surgery or open biopsy to establish a diagnosis

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    53. Behringer, D; Spyridonidis, A; Fetscher, S; Schmitt-Graff, A; Hogerle, S; Kaiser, R
      Paraneoplastic polyneuropathy preceding the diagnosis of Hodgkin's diseaseand non-small cell lung cancer in a patient with concomitant Borrelia burgdorferi infection

      ANNALS OF HEMATOLOGY
    54. Shwaiki, A; Lara, L; Ahmed, F; Crock, R; Rutecki, GW; Whittier, FC
      Acquired inhibitor to factor VIII in small cell lung cancer: a case reportand review of the literature

      ANNALS OF HEMATOLOGY
    55. Quddus, AMMZ; Kerr, GR; Price, A; Gregor, A
      Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy

      CLINICAL ONCOLOGY
    56. Snee, M
      Single-agent mitomycin for advanced non-small cell lung cancer

      CLINICAL ONCOLOGY
    57. Vansteenkiste, JF; Vandebroek, JE; Nackaerts, KL; Weynants, P; Valcke, YJ; Verresen, DA; Devogelaere, RC; Marien, SA; Humblet, YP; Dams, NL
      Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine

      ANNALS OF ONCOLOGY
    58. Skarlos, DV; Samantas, E; Briassoulis, E; Panoussaki, E; Pavlidis, N; Kalofonos, HP; Kardamakis, D; Tsiakopoulos, E; Kosmidis, P; Tsavdaridis, D; Tzitzikas, J; Tsekeris, P; Kouvatseas, G; Zamboglou, N; Fountzilas, G
      Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

      ANNALS OF ONCOLOGY
    59. Merimsky, O; Staroselsky, A; Inbar, M; Schwartz, Y; Wigler, N; Mann, A; Marmor, S; Greif, J
      Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    60. Quoix, E; Breton, JL; Daniel, C; Jacoulet, P; Debieuvre, D; Paillot, N; Kessler, R; Moreau, L; Coetmeur, D; Lemarie, E; Milleron, B
      Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study

      ANNALS OF ONCOLOGY
    61. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    62. van Putten, JWG; Kerbush, T; Smit, EF; van Rijswijk, R; Beijnen, JH; Sleijfer, DT; Groen, HJM
      Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    63. Vansteenkiste, J; Gatzemeier, U; Manegold, C; Hanauske, A; Weynants, P; Bosquee, L; Blatter, J; Mansouri, K; von Pawel, J
      Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study

      ANNALS OF ONCOLOGY
    64. Hirsch, FR; Osterlind, K; Jeppesen, N; Dombernowsky, P; Ingeberg, S; Sorensen, PG; Kristensen, C; Hansen, HH
      Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients

      ANNALS OF ONCOLOGY
    65. Mavroudis, D; Papadakis, E; Veslemes, M; Tsiafaki, X; Stavrakakis, J; Kouroussis, C; Kakolyris, S; Bania, E; Jordanoglou, J; Agelidou, M; Vlachonicolis, J; Georgoulias, V
      A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer

      ANNALS OF ONCOLOGY
    66. van der Lee, I; Smit, EF; van Putten, JWG; Groen, HJM; Schlosser, NJJ; Postmus, PE; Schramel, FMNH
      Single-agent gemcitabine in patients with resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    67. Kao, A; Shiun, SC; Hsu, NY; Sun, SS; Lee, CC; Lin, CC
      Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lungcancer

      ANNALS OF ONCOLOGY
    68. Tjan-Heijnen, VCG; Postmus, PE; Ardizzoni, A; Manegold, C; Burghouts, J; van Meerbeeck, J; Gans, S; Mollers, M; Buchholz, E; Biesma, B; Legrand, C; Debruyne, C; Giaccone, G
      Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

      ANNALS OF ONCOLOGY
    69. Feliu, J; Martin, G; Lizon, J; Chacon, JI; Dorta, J; de Castro, J; Rodriguez, A; Heras, BS; Torrego, JC; Espinosa, E; Baron, MG
      Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study

      ANNALS OF ONCOLOGY
    70. Gridelli, C; Perrone, F; Nelli, F; Ramponi, S; De Marinis, F
      Quality of life in lung cancer patients

      ANNALS OF ONCOLOGY
    71. Terzolo, M; Reimondo, G; Ali, A; Bovio, S; Daffara, F; Paccotti, P; Angeli, A
      Ectopic ACTH syndrome: Molecular bases and clinical heterogeneity

      ANNALS OF ONCOLOGY
    72. Carnaghi, C; Rimassa, L; Garassino, I; Santoro, A
      Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    73. Kagawa, K; Fujitaka, K; Isobe, T; Yamasaki, M; Miyazaki, M; Oguri, T; Kohno, N
      Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion

      INTERNAL MEDICINE
    74. Aratani, T; Narabayashi, I; Komori, T; Utsunomiya, K; Sueyoshi, K; Tachibana, S; Sasaki, S
      Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression levels in non-small cell lung cancer - a preliminary report

      ANNALS OF NUCLEAR MEDICINE
    75. Yamamoto, Y; Nishiyama, Y; Fukunaga, K; Satoh, K; Fujita, J; Ohkawa, M
      Tc-99m-MIBI SPECT in small cell lung cancer patients before chemotherapy and after unresponsive chemotherapy

      ANNALS OF NUCLEAR MEDICINE
    76. Nokihara, H; Yano, S; Nishioka, Y; Hanibuchi, M; Higasida, T; Tsuruo, T; Sone, S
      A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    77. Kshivets, O
      Immune cell and humoral circuit in prediction of non-small cell lung cancer patients survival after complete resections

      JOURNAL OF TUMOR MARKER ONCOLOGY
    78. Salminen, E; Mac Manus, M
      Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer

      ANNALS OF MEDICINE
    79. Lebeau, B; Urban, T; Baud, M; Collon, T; Le Guen, Y; Febvre, M; Touboul, E
      Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer

      REVUE DES MALADIES RESPIRATOIRES
    80. Muller, H; Guadagni, S
      Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    81. Rinaldi, D; Lormand, N; Brierre, J; Cole, J; Barnes, B; Fontenot, F; Buller, E; Rainey, J
      A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3)

      CANCER INVESTIGATION
    82. Kalemkerian, GP; Ali, MA; Luthra, K; Wozniak, AJ; Valdivieso, M; Kraut, MJ
      A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer

      CANCER INVESTIGATION
    83. Giovanella, L; Ceriani, L; Bandera, M; Garancini, S
      Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    84. Erkisi, M; Erkurt, E; Zeren, H; Tunali, C; Kocabas, A; Burgut, R
      Anticipated administration of GM-CSF in the treatment of non small cell lung cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    85. Malayeri, R; Pirker, R; Huber, H
      New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer

      ONKOLOGIE
    86. Plataniotis, GA; Theofanopoulou, MA
      Treatment of inoperable stage III and IV non-small-cell lung cancer: The 'average' radiotherapist's point of view

      ONKOLOGIE
    87. Pletcher, MT; Nobukuni, T; Fukuhara, H; Kuramochi, M; Maruyama, T; Sekiya, T; Sussan, T; Isomura, M; Murakami, Y; Reeves, RH
      Identification of tumor suppressor candidate genes by physical and sequence mapping of the TSLC1 region of human chromosome 11q23

      GENE
    88. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    89. Kurata, T; Tamura, T; Shinkai, T; Ohe, Y; Kunitoh, H; Kodama, T; Kakinuma, R; Matsumoto, T; Kubota, K; Omatsu, H; Nishiwaki, Y; Saijo, N
      Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    90. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    91. Imai, R; Hayakawa, K; Sakurai, H; Nakayama, Y; Mitsuhashi, N; Niibe, H
      Small cell lung cancer with a brain metastasis controlled for 5 years: a case report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    92. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    93. Tsuchiya, S; Ohe, Y; Sugiura, T; Fuwa, N; Kitamoto, Y; Mori, K; Kobayashi, H; Nakata, K; Sawa, T; Hirai, K; Etoh, T; Saka, H; Saito, A; Fukuda, H; Ishizuka, N; Saijo, N
      Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    94. Sim, S; Rosenzweig, KE; Schindelheim, R; Ng, KK; Leibel, SA
      Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    95. Hirota, S; Tsujino, K; Endo, M; Kotani, Y; Satouchi, M; Kado, T; Hishikawa, Y; Obayashi, K; Takada, Y; Kono, M; Abe, M
      Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    96. Rosenzweig, KE; Sim, SE; Mychalczak, B; Braban, LE; Schindelheim, R; Leibel, SA
      Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    97. Mac Manus, MP; Hicks, RJ; Matthews, JP; Hogg, A; McKenzie, AF; Wirth, A; Ware, RE; Ball, DL
      High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    98. Kotalik, J; Yu, E; Markman, BR; Evans, WK
      Practice guideline on prophylactic cranial irradiation in small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    99. Jeremic, B; Shibamoto, Y; Acimovic, L; Milicic, B; Milisavljevic, S; Nikolic, N; Dagovic, A; Aleksandrovic, J; Radosavljevic-Asic, G
      Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    100. Mehta, M; Scrimger, R; Mackie, R; Paliwal, B; Chappell, R; Fowler, J
      A new approach to dose escalation in non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 14:59:34